BLMN Stock Analysis: Bloomin Brands | NASDAQ
Restaurants | NASDAQ, USA | Market Cap: 897m USD | 12M Return: 55.5% | US0942351083 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 19.8M
EPS Trend: -94.0%
Qual. Beats: 2
Rev. Trend: -75.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bloomin Brands (NASDAQ: BLMN) is a Tampa, Florida-based restaurant company founded in 1988 that owns and operates a portfolio of four dining concepts in the United States and internationally. Its brands include Outback Steakhouse, Carrabbas Italian Grill, Bonefish Grill, and Flemings Prime Steakhouse & Wine Bar, spanning casual, polished-casual, and fine dining formats.
The company operates through U.S. and International Franchise segments, combining company-owned locations with a franchised distribution model that extends its brands into foreign markets. Bloomin Brands is classified in the GICS Restaurants sub-industry within Consumer Discretionary, a sector whose performance is closely tied to discretionary consumer spending, and trades as a small-cap stock with a market capitalization of roughly $710 million after its August 2012 IPO.
- Outback Steakhouse same-store sales drive consolidated revenue growth
- Beef and commodity cost inflation pressures restaurant-level margins
- Brazil international segment currency translation and demand volatility
- Debt reduction and share repurchase program execution returns capital
| Net Income: 27.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.88 > 1.0 |
| NWC/Revenue: -15.44% < 20% (prev -12.07%; Δ -3.37% < -1%) |
| CFO/TA 0.10 > 3% & CFO 319.8m > Net Income 27.7m |
| Net Debt (3.06b) to EBITDA (233.7m): 13.08 < 3 |
| Current Ratio: 0.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.2m) vs 12m ago 1.27% < -2% |
| Gross Margin: 40.14% > 18% (prev 29.52%; Δ 10.61% > 0.5%) |
| Asset Turnover: 123.9% > 50% (prev 111.5%; Δ 12.35% > 0%) |
| Interest Coverage Ratio: 1.11 > 6 (EBIT TTM 52.3m / Interest Expense TTM 47.0m) |
| A: -0.20 (Total Current Assets 209.6m - Total Current Liabilities 824.0m) / Total Assets 3.12b |
| B: -0.27 (Retained Earnings -830.6m / Total Assets 3.12b) |
| C: 0.02 (EBIT TTM 52.3m / Avg Total Assets 3.21b) |
| D: 0.16 (Book Value of Equity 431.8m / Total Liabilities 2.68b) |
| Altman-Z'' = -1.88 = D |
| DSRI: 0.22 (Receivables 42.0m/179.6m, Revenue 3.98b/3.69b) |
| GMI: 0.74 (GM 29.52% / 40.14%) |
| AQI: 1.09 (AQ_t 0.33 / AQ_t-1 0.31) |
| SGI: 1.08 (Revenue 3.98b / 3.69b) |
| TATA: -0.09 (NI 27.7m - CFO 319.8m) / TA 3.12b) |
| Beneish M = -3.81 (Cap -4..+1) = AAA |
As of August 27, 2026, the stock is trading at USD 11.15 with a total of 1,855,120 shares traded. Over the past week, the price has changed by +5.09%, over one month by +30.56%, over three months by +40.78% and over the past year by +55.51%.
Current recommended Stop Loss: 9.80 (which is 12.1% or 2.1 ATR below the current price).
Bloomin Brands has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold BLMN.
- StrongBuy: 1
- Buy: 0
- Hold: 10
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 11.3 | 1.5% |
P/E Trailing = 32.75
P/E Forward = 6.2461
P/S = 0.2255
P/B = 2.1017
P/EG = 1.07
Revenue TTM = 3.98b USD
EBIT TTM = 52.3m USD
EBITDA TTM = 233.7m USD
Long Term Debt = 702.8m USD (from longTermDebt, last quarter)
Short Term Debt = 176.8m USD (from shortTermDebt, last quarter)
Debt = 3.12b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.21b
Net Debt = 3.06b USD (calculated: Debt 3.12b - CCE 66.6m)
Enterprise Value = 3.95b USD (897.3m + Debt 3.12b - CCE 66.6m)
Interest Coverage Ratio = 1.11 (Ebit TTM 52.3m / Interest Expense TTM 47.0m)
EV/FCF = 25.51x (Enterprise Value 3.95b / FCF TTM 155.0m)
FCF Yield = 3.92% (FCF TTM 155.0m / Enterprise Value 3.95b)
FCF Margin = 3.89% (FCF TTM 155.0m / Revenue TTM 3.98b)
Net Margin = 0.70% (Net Income TTM 27.7m / Revenue TTM 3.98b)
Gross Margin = 40.14% ((Revenue TTM 3.98b - Cost of Revenue TTM 2.38b) / Revenue TTM)
Gross Margin QoQ = 13.97% (prev 11.04%)
Tobins Q-Ratio = 1.27 (Enterprise Value 3.95b / Total Assets 3.12b)
Interest Expense / Debt = 1.51% (Interest Expense 47.0m / Debt 3.12b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 41.3m (EBIT 52.3m * (1 - 21.00%))
Current Ratio = 0.25 (Total Current Assets 209.6m / Total Current Liabilities 824.0m)
Debt / Equity = 7.23 (Debt 3.12b / totalStockholderEquity, last quarter 431.8m)
Debt / EBITDA = 13.08 (Net Debt 3.06b / EBITDA 233.7m)
Debt / FCF = 19.72 (Net Debt 3.06b / FCF TTM 155.0m)
Total Stockholder Equity = 376.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.86% (Net Income 27.7m / Total Assets 3.12b)
RoE = 7.35% (Net Income TTM 27.7m / Total Stockholder Equity 376.3m)
RoCE = 4.84% (EBIT 52.3m / Capital Employed (Equity 376.3m + L.T.Debt 702.8m))
RoIC = 1.72% (NOPAT 41.3m / Invested Capital 2.40b)
WACC = 3.66% (E(897.3m)/V(4.02b) * Re(12.26%) + D(3.12b)/V(4.02b) * Rd(1.51%) * (1-Tc(0.21)))
Discount Rate = 12.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -49.19 | Cagr: -0.41%
[DCF] Terminal Value 77.97% ; FCFF base≈120.7m ; Y1≈138.3m ; Y5≈203.6m
[DCF] Fair Price = 0.09 (EV 3.06b - Net Debt 3.06b = Equity 7.77m / Shares 85.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
[DCF] Fair Price = 0.09 (out of range, set to none)
EPS Correlation: -94.02 | EPS CAGR: -31.76% | SUE: 1.33 | # QB: 2
Revenue Correlation: -75.80 | Revenue CAGR: -7.47% | SUE: 0.08 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.23 | Chg30d=-23.89% | Revisions=-75% | Analysts=11
EPS current Year (2026-12-31): EPS=0.97 | Chg30d=+9.81% | Revisions=+77% | GrowthEPS=-15.0% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=1.04 | Chg30d=+7.24% | Revisions=+62% | GrowthEPS=+7.1% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: +28% (up=19, down=10)